Program Adds Targeted Nutrition to Genetic Engineering to Fuel Spider Silk Proteins

ANN ARBOR, Mich., Nov. 02, 2026 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that its research and development team launched a new program to optimize the production and performance of key spider silk proteins. The program uses targeted dietary additives, selected to fuel the production of those proteins inside Kraig Labs’ genetically enhanced silkworms.

Kraig Labs has spent years perfecting the genetics that instruct the silkworms what to build. This program focuses on optimizing the building blocks, as nutrition supplies critical fuel.

Nutritional research in sericulture is not new. Earlier work looked at supplementing the silkworm’s diet to improve silk in general. Kraig Labs is taking a different, targeted approach focused on fueling spider silk proteins specifically. The program will provide key dietary building blocks to fuel the silkworm’s own internal silk production. The goal is to promote optimal protein production and construction of key spider silk proteins.

“Our silkworms are already extraordinary silk factories,” said Kim Thompson, Founder and CEO of Kraig Labs. “We have engineered them to produce spider silk proteins. Now we are working to fuel those exact proteins from the inside. This is a new lever for performance and it works in collaboration with everything we are already doing in genetics.”

Kraig Labs believes the program could improve both the output and quality of its recombinant spider silk. The work is in its early stages. The R&D team is evaluating candidate additives and measuring their effect on spider silk protein production and fiber performance.

“Dietary nutrition is key for optimal silk production,” said Dr. Xiaoli Zhang, Chief Scientist at Kraig Labs. “By targeting specific dietary components, we can enhance the production of the spider silk proteins our genetic constructs are designed to express. Initial results show positive signs. We are excited to explore how much further this approach can take us.”

The program adds to Kraig Labs’ growing R&D efforts. It joins the Company’s work in advanced genetic engineering, new transgenic development, and production scale-up. Together, they aim to strengthen both the performance of Kraig Labs’ spider silk and the efficiency of the production system behind it.

The Company’s leadership in biomaterials was recently spotlighted on the cover of the March 2026 issue of National Geographic, highlighting the growing importance and predominance of our work in scaling spider silk production.

Interested persons can order a copy of National Geographic featuring Kraig Labs at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026.

You can purchase a digital copy of the article directly from National Geographic at https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering.

You can see Kraig Labs featured in Veritasium’s spider silk video at https://www.youtube.com/watch?v=wt4p2oalmRY.

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

* For a description of our historical leadership in this technology, please follow this link https://www.kraiglabs.com/world-leader/.

Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward-looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com

Program Adds Targeted Nutrition to Genetic Engineering to Fuel Spider Silk Proteins

ANN ARBOR, Mich., Nov. 02, 2026 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that its research and development team launched a new program to optimize the production and performance of key spider silk proteins. The program uses targeted dietary additives, selected to fuel the production of those proteins inside Kraig Labs’ genetically enhanced silkworms.

Kraig Labs has spent years perfecting the genetics that instruct the silkworms what to build. This program focuses on optimizing the building blocks, as nutrition supplies critical fuel.

Nutritional research in sericulture is not new. Earlier work looked at supplementing the silkworm’s diet to improve silk in general. Kraig Labs is taking a different, targeted approach focused on fueling spider silk proteins specifically. The program will provide key dietary building blocks to fuel the silkworm’s own internal silk production. The goal is to promote optimal protein production and construction of key spider silk proteins.

“Our silkworms are already extraordinary silk factories,” said Kim Thompson, Founder and CEO of Kraig Labs. “We have engineered them to produce spider silk proteins. Now we are working to fuel those exact proteins from the inside. This is a new lever for performance and it works in collaboration with everything we are already doing in genetics.”

Kraig Labs believes the program could improve both the output and quality of its recombinant spider silk. The work is in its early stages. The R&D team is evaluating candidate additives and measuring their effect on spider silk protein production and fiber performance.

“Dietary nutrition is key for optimal silk production,” said Dr. Xiaoli Zhang, Chief Scientist at Kraig Labs. “By targeting specific dietary components, we can enhance the production of the spider silk proteins our genetic constructs are designed to express. Initial results show positive signs. We are excited to explore how much further this approach can take us.”

The program adds to Kraig Labs’ growing R&D efforts. It joins the Company’s work in advanced genetic engineering, new transgenic development, and production scale-up. Together, they aim to strengthen both the performance of Kraig Labs’ spider silk and the efficiency of the production system behind it.

The Company’s leadership in biomaterials was recently spotlighted on the cover of the March 2026 issue of National Geographic, highlighting the growing importance and predominance of our work in scaling spider silk production.

Interested persons can order a copy of National Geographic featuring Kraig Labs at https://ngsingleissues.nationalgeographic.com/natgeo-march-2026.

You can purchase a digital copy of the article directly from National Geographic at https://www.nationalgeographic.com/science/article/spider-silk-silkworm-genetic-engineering.

You can see Kraig Labs featured in Veritasium’s spider silk video at https://www.youtube.com/watch?v=wt4p2oalmRY.

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.

For details about recent Kraig Labs advancements, please watch the Company’s investor updates at www.kraiglabs.com/videos or on the Company’s YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news.

* For a description of our historical leadership in this technology, please follow this link https://www.kraiglabs.com/world-leader/.

Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward-looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

ir@KraigLabs.com

   Heineken Holding N.V. reports transactions under its current

share buyback programme

Amsterdam 2 November 2026 – Heineken Holding N.V. (EURONEXT:HEIO; OTCQX: HKHHY), hereby reports transaction details related to the second tranche of up to circa €375 million tranche of its share buyback programme of up to circa €750 million as communicated on 12 February 2026.

From 26 October 2026 up to and including 30 October 2026 a total of 160,530 shares were repurchased on exchange at an average price of €74.34.

Up to and including 30 October 2026, a total of 4,740,122 shares were repurchased under the second tranche of the share buyback programme for a total consideration of €314,662,732.

Heineken Holding N.V. publishes on a weekly basis, every Monday, an overview of the progress of the share buyback programme on its website: https://www.heinekenholding.com/investors/share-information/share-buyback-programme

Enquiries

Media Heineken Holding N.V.    
Kees Jongsma    
tel. +31 6 54 79 82 53    
E-mail: cjongsma@spj.nl    
     
Media   Investors
Christiaan Prins   Tristan van Strien
Director of Global Communications   Global Director of Investor Relations
Marlous den Bieman   Lennart Scholtus / Chris Steyn
Head of Global Media   Investor Relations Manager / Senior Analyst
E-mail: pressoffice@heineken.com   E-mail: investors@heineken.com
Tel: +31-20-5239355   Tel: +31-20-5239590

Regulatory information:

This press release is issued in connection with the disclosure and reporting obligations as set out in Article 5(1)(b) Regulation (EU) 596/2014 and Article 2(2) of the Commission Delegated Regulation (EU) 2016/1052 that contains technical standards for buyback programs.

Editorial information:
Heineken Holding N.V. engages in no activities other than its participating interest in Heineken N.V. and the management or supervision of and provision of services to that company. HEINEKEN is the world’s pioneering beer company. It is the leading developer and marketer of premium and non-alcoholic beer and cider brands. Led by the Heineken® brand, the Group has a portfolio of more than 340 international, regional, local and specialty beers and ciders. With HEINEKEN’s over 85,000 employees, HEINEKEN brews the joy of true togetherness to inspire a better world. HEINEKEN’s dream is to shape the future of beer and beyond to win the hearts of consumers. HEINEKEN is committed to innovation, long-term brand investment, disciplined sales execution and focused cost management. Through “Brew a Better World”, sustainability is embedded in the business. HEINEKEN has a well-balanced geographic footprint with leadership positions in both developed and developing markets. HEINEKEN operates breweries, malteries, cider plants and other production facilities in more than 70 countries. Most recent information is available on www.heinekenholding.com and www.theheinekencompany.com and follow HEINEKEN on LinkedIn and Instagram.

Attachment

   Heineken Holding N.V. reports transactions under its current

share buyback programme

Amsterdam 2 November 2026 – Heineken Holding N.V. (EURONEXT:HEIO; OTCQX: HKHHY), hereby reports transaction details related to the second tranche of up to circa €375 million tranche of its share buyback programme of up to circa €750 million as communicated on 12 February 2026.

From 26 October 2026 up to and including 30 October 2026 a total of 160,530 shares were repurchased on exchange at an average price of €74.34.

Up to and including 30 October 2026, a total of 4,740,122 shares were repurchased under the second tranche of the share buyback programme for a total consideration of €314,662,732.

Heineken Holding N.V. publishes on a weekly basis, every Monday, an overview of the progress of the share buyback programme on its website: https://www.heinekenholding.com/investors/share-information/share-buyback-programme

Enquiries

Media Heineken Holding N.V.    
Kees Jongsma    
tel. +31 6 54 79 82 53    
E-mail: cjongsma@spj.nl    
     
Media   Investors
Christiaan Prins   Tristan van Strien
Director of Global Communications   Global Director of Investor Relations
Marlous den Bieman   Lennart Scholtus / Chris Steyn
Head of Global Media   Investor Relations Manager / Senior Analyst
E-mail: pressoffice@heineken.com   E-mail: investors@heineken.com
Tel: +31-20-5239355   Tel: +31-20-5239590

Regulatory information:

This press release is issued in connection with the disclosure and reporting obligations as set out in Article 5(1)(b) Regulation (EU) 596/2014 and Article 2(2) of the Commission Delegated Regulation (EU) 2016/1052 that contains technical standards for buyback programs.

Editorial information:
Heineken Holding N.V. engages in no activities other than its participating interest in Heineken N.V. and the management or supervision of and provision of services to that company. HEINEKEN is the world’s pioneering beer company. It is the leading developer and marketer of premium and non-alcoholic beer and cider brands. Led by the Heineken® brand, the Group has a portfolio of more than 340 international, regional, local and specialty beers and ciders. With HEINEKEN’s over 85,000 employees, HEINEKEN brews the joy of true togetherness to inspire a better world. HEINEKEN’s dream is to shape the future of beer and beyond to win the hearts of consumers. HEINEKEN is committed to innovation, long-term brand investment, disciplined sales execution and focused cost management. Through “Brew a Better World”, sustainability is embedded in the business. HEINEKEN has a well-balanced geographic footprint with leadership positions in both developed and developing markets. HEINEKEN operates breweries, malteries, cider plants and other production facilities in more than 70 countries. Most recent information is available on www.heinekenholding.com and www.theheinekencompany.com and follow HEINEKEN on LinkedIn and Instagram.

Attachment

REYKJAVIK, ICELAND (November 2, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that members of the management team will participate in upcoming investor conferences in November as follows:

  • UBS Global Biopharma Conference in London– fireside chat Tuesday, November 17 at 14:00 GMT (9:00 am ET).
  • 2026 Jefferies Global Healthcare Conference in London – presentation on Wednesday, November 18 at 14:30 GMT (9:30 am ET)
  • DNB Carnegie Healthcare Conference in Oslo – fireside chat on Tuesday, November 24 at 13:20 CET (7:20 am ET).
  • SEB Healthcare Seminar in Stockholm– fireside chat on Wednesday, November 25 at 10:40 CET (4:40 am ET).

Live audio webcasts will be available to investors and the general public on Alvotech’s website on our Events and Presentations page: https://www.alvotech.com/events in the 2026 Q4 section. After the live webcasts, a recording will also be available for up to 90 days.

For further information, contact:

Media
Benedikt Stefansson
Sarah MacLeod
alvotech.media@alvotech.com

Investors
Dr. Balaji V Prasad
Benedikt Stefansson
Mikaela Vilchez
alvotech.ir@alvotech.com

About Alvotech

Alvotech is a biotechnology company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high-quality, cost-effective products and services, enabled by a fully integrated approach and broad in-house capabilities. Five biosimilars are already approved and marketed in multiple global markets, including biosimilars to Humira® (adalimumab), Stelara® (ustekinumab), Simponi® (golimumab), Eylea® (aflibercept) and Prolia®/Xgeva® (denosumab). The current development pipeline includes nine disclosed biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the United States, Europe, Japan, China, and other Asian countries and large parts of South America, Africa and the Middle East. For more information, please visit https://www.alvotech.com. None of the information on the Alvotech website shall be deemed part of this press release.

For more information, please visit our  website.

REYKJAVIK, Iceland, Nov. 02, 2026 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that members of the management team will participate in upcoming investor conferences in November as follows:

  • UBS Global Biopharma Conference in London– fireside chat Tuesday, November 17 at 14:00 GMT (9:00 am ET).
  • 2026 Jefferies Global Healthcare Conference in London – presentation on Wednesday, November 18 at 14:30 GMT (9:30 am ET)
  • DNB Carnegie Healthcare Conference in Oslo – fireside chat on Tuesday, November 24 at 13:20 CET (7:20 am ET).
  • SEB Healthcare Seminar in Stockholm– fireside chat on Wednesday, November 25 at 10:40 CET (4:40 am ET).

Live audio webcasts will be available to investors and the general public on Alvotech’s website on our Events and Presentations page: https://www.alvotech.com/events in the 2026 Q4 section. After the live webcasts, a recording will also be available for up to 90 days.

For further information, contact:

Media
Benedikt Stefansson
Sarah MacLeod
alvotech.media@alvotech.com

Investors
Dr. Balaji V Prasad
Benedikt Stefansson
Mikaela Vilchez
alvotech.ir@alvotech.com

About Alvotech

Alvotech is a biotechnology company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high-quality, cost-effective products and services, enabled by a fully integrated approach and broad in-house capabilities. Five biosimilars are already approved and marketed in multiple global markets, including biosimilars to Humira® (adalimumab), Stelara® (ustekinumab), Simponi® (golimumab), Eylea® (aflibercept) and Prolia®/Xgeva® (denosumab). The current development pipeline includes nine disclosed biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech has formed a network of strategic commercial partnerships to provide global reach and leverage local expertise in markets that include the United States, Europe, Japan, China, and other Asian countries and large parts of South America, Africa and the Middle East. For more information, please visit https://www.alvotech.com. None of the information on the Alvotech website shall be deemed part of this press release.

For more information, please visit our  website.

Heineken N.V. reports the progress of transactions under its current
share buyback programme

Amsterdam, 2 November 2026 – Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) hereby reports transaction details related to the second € 750 million tranche of its € 1.5 billion share buyback programme as communicated on 12 February 2026.

From 26 October 2026 up to and including 30 October 2026 a total of 159,700 shares were repurchased on exchange at an average price of € 77.94. During the same period, 160,530 shares were repurchased from Heineken Holding N.V.

Up to and including 30 October 2026, a total of 9,510,681 shares were repurchased under the second tranche of the share buyback programme for a total consideration of € 679,219,878 (including shares repurchased from Heineken Holding N.V.).

Heineken N.V. publishes on a weekly basis, every Monday, an overview of the progress of the share buyback programme on its website: https://www.theheinekencompany.com/investors/share-information/share-buyback-programme

 Enquiries  
Media Investors
Christiaan Prins Tristan van Strien
Director of Global Communication Global Director of Investor Relations
Marlous den Bieman Lennart Scholtus / Isabelle van Rongen
Head of Global Media, Issues and Crises Investor Relations Manager / Investor Relations Manager
E-mail: pressoffice@heineken.com E-mail: investors@heineken.com
Tel: +31-20-5239355 Tel: +31-20-5239590

Regulatory information
This press release is issued in connection with the disclosure and reporting obligations as set out in Article 5(1)(b) Regulation (EU) 596/2014 and Article 2(2) of the Commission Delegated Regulation (EU) 2016/1052 that contains technical standards for buyback programs.

Editorial information:
HEINEKEN is the world’s pioneering beer company. It is the leading developer and marketer of premium and non-alcoholic beer and cider brands. Led by the Heineken® brand, the Group has a portfolio of more than 340 international, regional, local and specialty beers and ciders. With HEINEKEN’s over 85,000 employees, we brew the joy of true togetherness to inspire a better world. Our dream is to shape the future of beer and beyond to win the hearts of consumers. We are committed to innovation, long-term brand investment, disciplined sales execution and focused cost management. Through “Brew a Better World”, sustainability is embedded in the business. HEINEKEN has a well-balanced geographic footprint with leadership positions in both developed and developing markets. We operate breweries, malteries, cider plants and other production facilities in more than 70 countries. Most recent information is available on our Company’s website and follow us on LinkedIn and Instagram.

Attachment

Independent Audit Validates Data Security Controls Across Xtract One View, SmartGateway, and Xtract One Gateway

TORONTO, Nov. 02, 2026 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced the successful completion of its System and Organization Controls (SOC) 2 Type II audit, conducted by an independent third-party auditing firm. The audit evaluated Xtract One’s internal security controls, data protection practices, and product architecture across its Xtract One View cloud platform, SmartGateway, and Xtract One Gateways.

For Fortune 500 companies, enterprise facilities, and the regulated environments Xtract One serves across healthcare, government, and large-scale deployments, the certification provides verified assurance that the telemetry, analytics, and operational data generated by Xtract One’s physical screening systems are protected by continuously tested, enterprise-grade security controls. Vendor data security documentation is a requirement of the procurement and onboarding process for organizations of this scale, and SOC 2 Type II certification addresses that requirement directly.

Developed by the American Institute of Certified Public Accountants (AICPA), a SOC 2 Type II audit examines a service organization’s internal controls over a continuous period rather than at a single point in time. The audit tests the operating effectiveness of those controls across security, availability, and confidentiality, providing documented evidence that a company consistently adheres to rigorous data protection standards throughout its operations.

“As Fortune 500 companies and large enterprise organizations continue to select Xtract One, we’re pleased to meet the advanced security requirements they bring to every vendor relationship,” said Peter Evans, CEO of Xtract One. “Organizations that keep security as a priority apply rigorous evaluation across every dimension of a solution, from operational considerations to IT integration to cybersecurity, and most importantly the overall effectiveness of the physical security program itself. SOC 2 Type II is an ongoing validation to those organizations that Xtract One delivers solutions that are as secure as they are effective.”

“Our customers trust us to protect the physical safety of their patrons, students, and patients,” said Joshua Douglas, SVP of Product and Engineering, Xtract One. “In today’s environment, physical security and data security are directly connected. The data flowing through our systems, the screening metrics, the system health analytics, the cloud communications, carries the same responsibility as the detection itself. SOC 2 Type II certification is our public commitment that we hold those controls to the same standard our customers expect from their enterprise technology partners.”

The audit covered Xtract One View, the Company’s centralized cloud management platform for fleet oversight, real-time analytics, and remote system management, as well as the connected hardware systems that feed it. The certification confirms that Xtract One’s cloud infrastructure and endpoint architecture operate under verified data privacy controls, proactive vulnerability management, and documented incident response protocols.

To learn more, visit www.xtractone.com.

About Xtract One
Xtract One Technologies is a leading technology-driven provider of threat detection and security solutions leveraging AI to deliver seamless and secure experiences. The Company makes unobtrusive weapons and threat detection systems that are designed to assist facility operators in prioritizing- and delivering improved “Walk-right-In” experiences while enhancing safety. Xtract One’s innovative portfolio of AI-powered Gateway solutions excels at allowing facilities to discreetly screen and identify weapons and other threats at points of entry and exit without disrupting the flow of traffic. With solutions built to serve the unique market needs for schools, hospitals, arenas, stadiums, manufacturing, distribution, and other customers, Xtract One is recognized as a market leader delivering the highest security in combination with the best individual experience. For more information, visit www.xtractone.com or connect on Facebook, X, and LinkedIn.

About Threat Detection Systems
Xtract One solutions, when properly configured, deployed, and utilized, are designed to help enhance safety and reduce threats. Given the wide range of potential threats in today’s world, no threat detection system is 100% effective. Xtract One solutions should be utilized as one element in a multilayered approach to physical security.

Forward Looking Statements
This news release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance and customer contracts, are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, but are not limited to, the risks detailed from time to time in the continuous disclosure filings made by the Company with securities regulations. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company has no obligation to update any forward looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

For further information, please contact:
Xtract One Inquiries: info@xtractone.com, http://www.xtractone.com
Investor Relations: Mark Kuindersma, LodeRock Advisors, mark.kuindersma@loderockadvisors.com, 519-501-0545
Media Contact: Kristen Aikey, JMG Public Relations, kristen@jmgpr.com, 212-206-1645

VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), Canada’s leading licensed producer of premium cannabis products, is pleased to announce that it will be reporting its financial results for the period ended September 30, 2026 (“Q3 2026”) before market opening on Monday, November 16.  

Q3 2026 Conference Call

The Company will be hosting a conference call to discuss the results on Monday, November 16, 2026. Conference call details are as follows:

Time: 8:00 AM PCT / 10:00 AM EST
Conference ID: 45311
Local dial-in:  (+1) 289 514 5100
Toll Free N. America: (+1) 800 717 1738
Webcast: https://onlinexperiences.com/Launch/QReg/ShowUUID=CEB4A826-A47C-465A-BCF9-EE215FEF43CB

PSU Grant

On July 20, 2026, the Company announced that 686,786 performance share units held by certain executives had been forfeited and cancelled. On September 24, 2026, the Company granted 686,786 performance share units to such executives on substantially the same economic terms and vesting schedule as the forfeited performance share units.

ABOUT RUBICON ORGANICS INC.

Rubicon Organics is a Canadian leader in certified organic and premium cannabis, with a portfolio of trusted brands including Simply Bare™ Organics, 1964 Supply Co.™, Wildflower™, and Homestead Cannabis Supply™.

The Company operates the 125,000-square-foot Pacifica hybrid greenhouse in Delta, British Columbia, and the 47,500-square-foot Cascadia indoor facility in Hope, British Columbia, with current annual production capacity of approximately 15,500 kilograms of premium cannabis, expanding to 20,000 kilograms by mid 2027. Rubicon’s proprietary genetics, award-winning products and international certifications support its growth in Canada and regulated international markets.

For more information visit www.rubiconorganics.com.

CONTACT INFORMATION

Margaret Brodie
CEO
Phone: +1 (437) 929-1964
Email: ir@rubiconorganics.com

The TSX Venture Exchange or its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.

Cautionary Statement Regarding Forward Looking Information

This press release contains forward-looking information within the meaning of applicable securities laws. Forward-looking information can be identified by the use of words such as “will”, “expected”, “anticipated”, “continue”, “positioned”, “opportunities”, “potential” or variations of such words or statements that certain actions, events or results may, could, would, should, might or will occur or be achieved. Forward-looking information includes, but is not limited to, statements regarding the timing of the release of the Company’s Q3 2026 financial results and the timing of the Company’s related conference call.

Forward-looking information is subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements of the Company to differ materially from those expressed or implied by such forward-looking information. These risks and uncertainties include, but are not limited to: the risk that the timing of the release of the Company’s Q3 2026 financial results or the related conference call may change; changes in general economic or market conditions; shifts in consumer demand; changes in applicable laws or regulatory requirements governing the cannabis industry; the ability to obtain necessary approvals, including approval from the TSX Venture Exchange; and other risk factors described in the Company’s public disclosure filings available on SEDAR+ at www.sedarplus.ca. 

Readers are cautioned not to place undue reliance on such forward-looking information. Although the Company has attempted to identify important risk factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information.

All forward-looking information in this press release is made as of the date hereof and is based on the beliefs, estimates, and opinions of management as of the date such statements are made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable law.

EDMONTON, Alberta, Nov. 02, 2026 (GLOBE NEWSWIRE) — Capital Power Corporation (TSX: CPX) today released financial results for the quarter ended September 30, 2026.

Highlights

  • Long-term Energy Supply Agreement (ESA) for 250 megawatts of capacity and energy with Meta Platforms, Inc. in support of a data centre
  • Subsequent to the quarter, the 100MW expansion at East Windsor received approval to operate in the Ontario market
  • Generated net cash flows from operating activities of $381 million and adjusted funds from operations (AFFO)1 of $306 million
  • Generated net income of $67 million and adjusted EBITDA1 of $553 million
  • Increased annual common share dividend by 2%, representing the 13th consecutive year of increase

CEO Message

Our third-quarter results reflect the continued execution of our strategy and the value of our diversified portfolio, with strong contributions from our Alberta, PJM and Ontario assets. Our portfolio pairs stable contracted cash flows with exposure to markets where growing electricity demand and tightening supply are creating meaningful upside.

Approximately 75% of our expected 2026 adjusted EBITDA is underpinned by long-term contracts. Indicative of our strategy of working with high-quality counterparties, 100% of our power purchase agreements are held with investment grade counterparties and over 70% are utilities or system operators. Our Energy Supply Agreement with Meta is the latest example of these efforts to secure longer-term cash flows across our core markets. Over the past 18 months, we have delivered on ~2 GW of contracted capacity with a weighted average contract life of approximately 15 years.

With a strong balance sheet and disciplined capital allocation, we are also evaluating opportunities to extract additional value from our existing sites through uprates, expansions and co-located battery storage. These opportunities support our focus on growth and shareholder returns. The 2% annual dividend increase announced in the second quarter marks the 13th consecutive year of increase.

Revised 2026 Annual Guidance

Priority 2026 targets Status at September 30, 2026
Generate financial
stabilityand strength

AFFO 3 of $890 million to $1,010 million $788 million ‎1
Adjusted EBITDA 3 of $1,565 million to
$1,765 million
$1,308 million ‎1
Execution of major  Sustaining capital expenditures 4
$270 million ‎1,‎2
turnarounds Revised target:
$350 million to
$370 million
Original target:
$290 million to
$330 million
 
Portfolio optimization Re-contract/contract natural gas generation
Maximize facility asset life and value
In July, the Company entered into a long-term ESA with Meta for 250 MW of capacity and energy in support of a data centre in Alberta.

In Q1 2026, the Company extended its summer tolling agreement for Arlington Valley from 2031 to October 2038. As part of this agreement, the facility will undergo a 35 MW capacity uprate.

Discussions with counterparties to supply energy solutions from across our fleet are in progress.

Expand flexible generation portfolio Continue construction on Ontario growth and commercial initiative projects
Continue to explore opportunities to build or acquire natural gas generation facilities
Construction is underway and the projects are progressing to meet their targeted completion dates. Subsequent to the quarter, the 100MW expansion at East Windsor received approval to operate in the Ontario market.
Grow renewables portfolio Continue construction of North Carolina growth projects
Continue to explore opportunities to build or acquire renewables facilities
Construction for the North Carolina solar projects continued into 2026. Commissioning activities for Hornet and Bear Branch Solar are progressing towards a Q4 2026 completion.
Advance balanced energy solutions such as low-carbon solutions Evaluate SMRs in Alberta

Continue to explore opportunities to co-locate with data centres across North America

Pre-feasibility study work for the Alberta SMR project with Ontario Power Generation remains on track, and we continue to evaluate the development opportunity through this project.

We remain in various stages of discussion with several prospective customers about the potential to co-locate or otherwise serve data centre demand at our sites across North America.

  1. For the nine months ended September 30, 2026.
  2. Net of partner contributions of $10 million and including our share of equity-accounted investments sustaining capital expenditures of $38 million.
  3. AFFO and adjusted EBITDA are non-GAAP financial measures. See Non-GAAP Financial Measures and Ratios.
  4. The Company revised its guidance range for 2026 sustaining capital expenditures reflecting unplanned outage work, primarily for the U.S. flexible generation fleet, and the advancement of a planned outage from 2027 into the fourth quarter of 2026 to ensure high reliability through 2027. The increase is event-driven, and a significant portion relates to insurable events. Insurance recoveries anticipated in 2026 and 2027, together with concessions from original equipment manufacturers (OEMs), are expected to meaningfully offset the cash impact.

Operational and Financial Highlights1

($ millions, except per share amounts) Three months ended
September 30,
Nine months ended
September 30,
  2026 2025 2026 2025
Electricity generation (Gigawatt hours) 2 14,485 13,374 36,090 31,951
Generation facility availability (%) 3 93 93 91 92
Revenues and other income 831 1,213 2,776 2,642
Net income 67 153 39 172
Net income attributable to shareholders of the Company 67 154 38 173
Basic earnings per share ($) 0.37 0.94 0.09 1.02
Diluted earnings per share ($) ‎4 0.37 0.94 0.09 1.01
Adjusted EBITDA ‎5 553 477 1,308 1,166
AFFO ‎5 306 369 788 822
AFFO per share ($) ‎5 1.94 2.37 5.03 5.53
Net cash flows from operating activities 381 404 907 757
Purchase of property, plant and equipment and other assets, net 167 147 642 576
Dividends per common share, declared ($) 0.7048 0.6910 2.0868 1.9948
  1. The operational and financial highlights in this press release should be read in conjunction with the Management’s Discussion and Analysis (MD&A) and the unaudited condensed interim financial statements for the nine months ended September 30, 2026.
  2. Gigawatt hours (GWh) of electricity generation reflects the Company’s share of facility output and includes GWh discharged from BESS.
  3. Facility availability represents the percentage of time in the period that the facility was available to generate power regardless of whether it was running and therefore is reduced by planned and unplanned outages.
  4. Diluted earnings per share was calculated after giving effect to outstanding share purchase options.
  5. The consolidated financial highlights, except for adjusted EBITDA, AFFO and AFFO per share were prepared in accordance with GAAP. See Non-GAAP Financial Measures and Ratios.

Revenues and other income decreased quarter-over-quarter due to unfavourable changes in unrealized fair value on commodity derivatives and emission credits, primarily in the U.S. flexible generation segment. Excluding these non-cash fair value changes, revenues and other income increased, driven by higher contributions from the U.S. flexible generation segment, where stronger PJM pricing and summer demand at Hummel Station and Rolling Hills and higher contracted revenues at Arlington Valley more than offset less favourable hedge settlements at La Paloma.

Adjusted EBITDA increased quarter-over-quarter primarily due to:

  • higher contributions from the Hummel Station and Rolling Hills facilities acquired in June 2025, reflecting stronger PJM power prices and summer demand in the third quarter and a full nine months of operations in 2026,
  • higher results in the Canada flexible generation segment, as favourable portfolio optimization, higher generation and pricing at Goreway, and contributions from the Ontario BESS projects that commenced operations in September 2025 more than offset the impact of lower Alberta spot power prices and lower generation,
  • partially offset by a lower contribution from La Paloma, where the financial hedges entered into following its acquisition settled less favourably than in 2025.

AFFO was $306 million and $788 million for the three and nine months ended September 30, 2026, respectively, compared with $369 million and $822 million in the corresponding periods in 2025. Despite higher adjusted EBITDA, as described above, AFFO for both the quarter and year-to-date periods was impacted by the following:

  • higher sustaining capital expenditures, primarily reflecting the heavy maintenance schedule for the Alberta fleet, rotor replacements at Rolling Hills and Harquahala, and a full year of planned maintenance at Hummel Station and Rolling Hills,
  • higher net finance expense,
  • current income tax expense of $35 million and $65 million for the three and nine months ended September 30, 2026, respectively, compared with income tax recoveries of $16 million and $72 million in the corresponding periods of 2025, reflecting higher taxable income due to lower tax depreciation, and
  • the non-cash straight-line recognition of capacity payments under the Arlington Valley summer tolling agreement, which contributed favourably to adjusted EBITDA, and which did not affect AFFO,
  • the year-to-date impacts were partially offset by the recognition of $174 million in Clean Technology ITCs for eligible Canadian renewables projects in the second quarter of 2026.

Analyst conference call and webcast

Capital Power will be hosting a conference call and live webcast with analysts on November 2, 2026 at 9:00 a.m. ABT (8:00 a.m. MT / 10:00 a.m. ET) to discuss the third quarter financial results. The webcast can be accessed at: https://edge.media-server.com/mmc/p/z44y8ypg/. Conference call details will be sent directly to analysts.

An archive of the webcast will be available on the Company’s website at www.capitalpower.com following the conclusion of the analyst conference call.

Non-GAAP Financial Measures and Ratios 

Capital Power uses (i) earnings before income tax expense, depreciation and amortization, net finance expense, foreign exchange gains or losses, gains or losses on disposals and other transactions, unrealized changes in fair value of commodity derivatives and emission credits, other expenses from our equity-accounted investments, acquisition and integration costs, and other items that are not reflective of the Company’s facility operating performance (adjusted EBITDA), and (ii) adjusted funds from operations (AFFO) as specified financial measures. Adjusted EBITDA and AFFO are both non-GAAP financial measures.

Capital Power also uses AFFO per share as a specified performance measure. This measure is a non-GAAP ratio determined by applying AFFO to the weighted average number of common shares used in the calculation of basic and diluted earnings per share.

These terms are not defined financial measures according to GAAP and do not have standardized meanings prescribed by GAAP and, therefore, are unlikely to be comparable to similar measures used by other enterprises. These measures should not be considered alternatives to net income, net income attributable to shareholders of Capital Power, net cash flows from operating activities or other measures of financial performance calculated in accordance with GAAP. Rather, these measures are provided to complement GAAP measures in the analysis of our results of operations from management’s perspective.

Adjusted EBITDA

Capital Power uses adjusted EBITDA to measure the operating performance of facilities and categories of facilities from period to period. Management believes that a measure of facility operating performance is more meaningful if results not related to facility operations are excluded from the adjusted EBITDA measure such as impairments, foreign exchange gains or losses, gains or losses on disposals and other transactions, unrealized changes in fair value of commodity derivatives and emission credits, acquisition and integration costs, and other items that are not reflective of the long-term performance of the Company’s underlying operations.

A reconciliation of adjusted EBITDA to net income is as follows:

($ millions) Three months ended
September 30,
Nine months ended
September 30,
  2026   2025   2026 2025  
Net income 67   153   39 172  
Depreciation and amortization 207   157   555 421  
Unrealized changes in fair value of commodity derivatives and emission credits 89   (13 ) 238 176  
Foreign exchange (gain) loss (2 ) 7   20 (16 )
Net finance expense 95   92   282 217  
Acquisition and integration costs –   4   – 41  
Loss on disposals and other transactions 17   5   17 12  
Other items1 45   37   142 110  
Other non-recurring items‎2 (2 ) –   – 4  
Income tax expense 37   35   15 29  
Adjusted EBITDA 553   477   1,308 1,166  
  1. Includes finance expense, depreciation expense and unrealized changes in fair value of derivative instruments from equity-accounted investments.
  2. For the three and nine months ended September 30, 2026, other non-recurring items reflect a partial reimbursement for a provision assumed in the acquisition of Hummel Station, LLC, related to overpayments to FERC and legal fees related to a dispute with a contractor regarding construction work on the Genesee Repowering project. The nine months ended September 30, 2025 reflects costs related to the end-of-life of Genesee coal operations.

AFFO and AFFO per share

AFFO and AFFO per share are measures of our ability to generate cash from our operating activities to fund growth capital expenditures, repayment of debt, and payment of common share dividends.

The Company’s AFFO definition includes government grants related to off-coal compensation to be received annually to 2030. During the second quarter of 2026, the Company updated the composition of AFFO and AFFO per share to reflect the introduction of similar government grants where cash grants form part of the operating returns on qualifying capital investment and support the Company’s cash generation and liquidity profile. As a result, AFFO and AFFO per share now include Clean Technology ITCs associated with eligible Canadian renewables projects.

The Company has included $174 million in government grants related to Clean Technology ITCs, representing approximately 30% of eligible Canadian renewables project costs. These amounts are included in AFFO and AFFO per share in the period in which the required filing with the applicable tax authority is completed, rather than when cash is received to eliminate timing variability associated with administrative processing. While Capital Power expects amounts ultimately received to be consistent with amounts filed, actual receipts may differ. The amendment did not impact previously reported AFFO or AFFO per share amounts.

AFFO represents net cash flows from operating activities adjusted to:

  • exclude timing impacts of cash receipts and payments that may impact period-to-period comparability by including deductions for net finance expense and current income tax expense, and excluding deductions for interest paid, deductions for income taxes paid and changes in operating working capital,
  • include our share of AFFO of equity-accounted investments and exclude distributions received from our equity-accounted investments which are calculated after the effect of non-operating activity equity-accounted investments debt payments,
  • include government grants which represent a portion of operating returns on capital investment recognized in the period that they are either contractually obligated to be received by Capital Power or the period in which Capital Power has completed the necessary filing with the applicable tax authority to eliminate timing uncertainty due to administrative filing processes,
  • exclude the tax equity financing project investors’ shares of AFFO associated with assets under tax equity financing structures so only Capital Power’s share is reflected in the overall metric,
  • deduct sustaining capital expenditures and preferred share dividends,
  • exclude the impact of fair value changes in certain unsettled derivative financial instruments that are charged or credited to our bank margin account held with a specific exchange counterparty,
  • exclude acquisition and integration costs, and
  • exclude other typically non-recurring items affecting cash flows from operating activities that are not reflective of the long-term performance of the Company’s underlying business.

A reconciliation of net cash flows from operating activities to AFFO is as follows:

($ millions except per share amounts) Three months ended
September 30,
Nine months ended
September 30,
  2026   2025   2026   2025  
Net cash flows from operating activities 381   404   907   757  
Add (deduct):        
Interest paid 95   87   254   202  
Change in fair value of derivatives reflected as cash settlement 4   —   10   7  
Realized gain on settlement of interest rate derivatives (12 ) —   (12 ) (17 )
Distributions received from equity-accounted investments (7 ) (9 ) (72 ) (47 )
Miscellaneous financing charges1 4   4   11   (2 )
Income taxes recovered (12 ) (11 ) (12 ) (14 )
Change in non-cash operating working capital (26 ) (77 ) (39 ) (23 )
  46   (6 ) 140   106  
Net finance expense 2 (87 ) (81 ) (258 ) (192 )
Current income tax (expense) recovery 3 (35 ) 16   (65 ) 72  
Sustaining capital expenditures 4 (87 ) (44 ) (232 ) (85 )
Preferred share dividends paid (7 ) (7 ) (22 ) (20 )
Government grants 5 50   50   224   60  
Remove tax equity interests’ respective shares of AFFO 1   (1 ) —   (4 )
AFFO from equity-accounted investments 43   38   98   101  
Acquisition and integration costs 6 —   3   (1 ) 41  
Other non-recurring items ‎7 1   (3 ) (3 ) (14 )
AFFO 306   369   788   822  
Weighted average number of common shares outstanding (millions) 157.4   155.3   156.8   148.6  
AFFO per share ($) 1.94   2.37   5.03   5.53  
  1. Included in other cash items on the condensed interim consolidated statements of cash flows to reconcile net income to net cash flows from operating activities.
  2. Excludes unrealized changes on interest rate derivative contracts, amortization, accretion charges, and non-cash implicit interest on tax equity investment structures.
  3. For the three and nine months ended September 30, 2025, excludes current income tax expense related to the partial divestiture of Quality Wind and Port Dover and Nanticoke Wind in 2024 as the amount is classified as an investing activity.
  4. Sustaining capital expenditures net of partner contributions of $1 million and $10 million for the three and nine months ended September 30, 2026, respectively, compared with $2 million and $8 million for the three and nine months ended September 30, 2025.
  5. For the nine months ended September 30, 2026, reflects recognition of $174 million in Clean Technology ITCs filed with the applicable tax authority, representing approximately 30% of eligible Canadian renewables project costs. For the three and nine months ended September 30, 2026 and September 30, 2025, reflects payments received from the Government of Alberta for the settlement of previously disputed off-coal compensation payments as described in the Company’s 2025 annual consolidated financial statements.
  6. For the nine months ended September 30, 2026, current income tax recoveries of $1 million related to prior period acquisition and integration costs. For the three and nine months ended September 30, 2025, net of current income tax recoveries of $1 million and $2 million.
  7. For the three months ended September 30, 2026, other non-recurring items included $3 million of legal costs related to a contractor dispute concerning construction work at the Genesee Repowering project, offset by a $5 million recovery from the settlement of the FERC reactive supply and voltage control service overpayment provision and current income tax expense of $3 million. For the nine months ended September 30, 2026, other non-recurring items included $5 million of legal costs related to a contractor dispute at the Genesee Repowering project, offset by a $5 million recovery from the settlement of the FERC reactive supply and voltage control service overpayment provision and current income tax recoveries of $3 million associated with non-recurring items recognized in prior periods. For the three months ended September 30, 2025, other non-recurring items reflect costs related to the termination of the Halkirk 2 Wind virtual power purchase agreement (VPPA) of $5 million, net of current income tax recoveries of $8 million related to other non-recurring items recognized in the current and prior periods. For the nine months ended September 30, 2025, other non-recurring items reflect costs related to the termination of the Halkirk 2 Wind VPPA and end-of-life of Genesee coal operations of $5 million each, net of current income tax recoveries of $24 million related to other non-recurring items recognized in the current and prior periods.

Forward-looking information

Forward-looking information or statements (collectively, “forward-looking information”) included in this press release are provided to inform our shareholders, potential investors and other stakeholders about management’s assessment of Capital Power’s future plans and operations. This information may not be appropriate for other purposes. The forward-looking information in this press release is generally identified by words such as will, anticipate, believe, plan, intend, target, and expect or similar words that suggest future outcomes.

Material forward-looking information in this press release includes, among other things, expectations regarding:

  • our 2026 adjusted EBITDA and revised sustaining capital expenditures targets, and
  • recoverability of insurance proceeds for submitted claims.

These statements are based on certain assumptions and analyses made by the Company in light of its experience and perception of historical trends, current conditions, expected future developments, and other factors it believes are appropriate including its review of purchased businesses and assets. The material factors and assumptions used to develop this forward-looking information relate to:

  • electricity and other energy (including natural gas) and carbon prices,
  • the Company’s performance,
  • the Company’s business prospects (including potential re-contracting of facilities) and opportunities including expected growth and capital projects,
  • the energy needs of certain jurisdictions,
  • the status and impact of policy, legislation and regulations,
  • effective tax rates,
  • the development and performance of technology,
  • the outcome of claims and disputes,
  • foreign exchange rates, and
  • other matters discussed under the Performance Outlook and Risks and Risk Management sections of the MD&A.

Whether actual results, performance or achievements will conform to our expectations and predictions is subject to a number of known and unknown risks and uncertainties which could cause actual results and experience to differ materially from our expectations. Such material risks and uncertainties include:

  • Meta’s completion of a data centre as contemplated in the ESA,
  • changes in electricity, natural gas and carbon prices in markets in which we operate and the use of derivatives,
  • regulatory and political environments including changes to environmental, climate, financial reporting, market structure and tax legislation,
  • disruptions, or price volatility within our supply chains,
  • generation facility availability, wind capacity factor and performance including maintenance expenditures,
  • ability to fund current and future capital and working capital needs,
  • acquisitions and developments including timing and costs of regulatory approvals and construction,
  • changes in market prices and the availability of fuel,
  • ability to realize the anticipated benefits of acquisitions,
  • limitations inherent in our review of acquired assets,
  • changes in general economic and competitive conditions, including inflation and recession,
  • changes in the performance and cost of technologies and the development of new technologies, new energy efficient products, services and programs, and
  • risks and uncertainties discussed under the Risks and Risk Management section of the MD&A.

See Risks and Risk Management in our 2025 Integrated Annual Report, for further discussion of these and other risks.

Readers are cautioned not to place undue reliance on any such forward-looking information, which speak only as of the date made and that other events or circumstances, although not listed above, could cause Capital Power’s actual results to differ materially from those estimated or projected and expressed in, or implied by the forward-looking information. Capital Power does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking information to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law.

About Capital Power

Capital Power is one of North America’s leading independent power producers, with approximately 12 GW of generation capacity across 35 facilities. Our portfolio includes natural gas, renewables, and battery energy storage solutions. We deliver power generation at utility-scale through a flexible and resilient fleet built to meet growing electricity demand. Backed by an investment-grade credit rating, we provide safe, reliable power communities can depend on.

For more information, please contact:

Media Relations: 
Katherine Perron
(780) 392-5335 
kperron@capitalpower.com
Investor Relations: 
Noreen Farrell
(403) 461-5236 
investor@capitalpower.com


1
AFFO and adjusted EBITDA are non-GAAP financial measures. See Non-GAAP Financial Measures and Ratios.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.